Medical technologies for the diagnosis of prostate cancer
Medical technologies for the diagnosis of prostate cancer
复制标题
DOI：
10.1586/17434440.4.2.227
复制
发表时间：
2007-03
影响因子：
3.1
通讯作者：
N. Fitzsimons;Leon L Sun;J. Moul
中科院分区：
文献类型：
--
作者：
N. Fitzsimons;Leon L Sun;J. Moul
前列腺癌是一个非常普遍的问题，尤其是在我们的老龄化人口中。前列腺特异性抗原检测彻底改变了前列腺癌筛查。在前列腺特异性抗原及其衍生物、生物标志物、诊断成像技术、活检策略、活检针设计和麻醉药物的使用方面取得了重大进展。前列腺癌检测的进一步改进取决于肿瘤特异性和对生物侵袭性敏感的成像技术的发展。
Prostate cancer is an extremely prevalent problem, especially in our aging population. The prostate-specific antigen test has revolutionized prostate cancer screening. Significant advances have been made in the usage of prostate-specific antigen and its derivatives, biomarkers, diagnostic imaging techniques, biopsy strategy, biopsy needle design and anesthetic agents. Further improvement in prostate cancer detection hinges on the development of an imaging technique that is tumor specific and sensitive to biological aggressiveness.